Biovie is trading at $1.57, up 9.03% in pre-market on October 7, 2026; the move’s cause remains unconfirmed.
- Shares closed at $1.44 on October 6.
- Biovie’s investor-relations news page lists no October 7 announcement; its latest listed release is dated September 15.
- Available market context is mixed, and no clear company-specific catalyst or reliable report explains the move.